European Growth Companies Insiders Are Investing In
October 22, 2025
In a mixed week for European markets, the pan-European STOXX Europe 600 Index edged higher amid dovish signals from the U.S. Federal Reserve and easing trade tensions between the U.S. and China, while major indexes such as Germany’s DAX and the UK’s FTSE 100 faced declines. In this environment, growth companies with high insider ownership often attract attention as they can indicate confidence in a company’s potential amidst fluctuating market conditions.
|
Name |
Insider Ownership |
Earnings Growth |
|
Xbrane Biopharma (OM:XBRANE) |
13% |
112.0% |
|
Pharma Mar (BME:PHM) |
11.9% |
44.2% |
|
MedinCell (ENXTPA:MEDCL) |
12.5% |
90.4% |
|
KebNi (OM:KEBNI B) |
36.3% |
74% |
|
Elliptic Laboratories (OB:ELABS) |
22.5% |
97.9% |
|
Egetis Therapeutics (OM:EGTX) |
10.3% |
85% |
|
CTT Systems (OM:CTT) |
17.5% |
37.9% |
|
Circus (XTRA:CA1) |
24.1% |
67.1% |
|
CD Projekt (WSE:CDR) |
29.7% |
39.7% |
|
Bonesupport Holding (OM:BONEX) |
10.4% |
59.4% |
Here we highlight a subset of our preferred stocks from the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Yubico AB offers authentication solutions for computers, networks, and online services, with a market cap of SEK9.87 billion.
Operations: The company’s revenue primarily comes from its Security Software & Services segment, which generated SEK2.34 billion.
Insider Ownership: 36.6%
Yubico’s growth potential is underscored by forecasted earnings growth of 33.1% annually, outpacing the Swedish market. Insider confidence is evident with substantial recent insider buying and no significant selling. The strategic partnership with Dashlane enhances Yubico’s position in passwordless security, leveraging its YubiKey technology for robust authentication solutions. Despite a recent dip in quarterly earnings, the company’s long-term prospects remain bolstered by high insider ownership and strategic leadership appointments.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV operates an online pharmacy business across several European countries, including the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France, with a market cap of approximately €1.74 billion.
Operations: The company’s revenue is divided into two main segments: DACH, contributing €2.18 billion, and International, accounting for €492.32 million.
Insider Ownership: 13.5%
Redcare Pharmacy demonstrates growth potential with a forecasted annual earnings increase of 56.32% and revenue growth outpacing the German market at 15.8%. Despite no substantial insider buying recently, the company trades significantly below its estimated fair value, suggesting potential undervaluation. Recent sales results show a robust 25.2% increase in Q3 2025 to €719 million, though executive changes may introduce transitional challenges as CFO Jasper Eenhorst departs after nearly six years.
-
Unlock comprehensive insights into our analysis of Redcare Pharmacy stock in this growth report.
-
Upon reviewing our latest valuation report, Redcare Pharmacy’s share price might be too optimistic.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Zalando SE operates an online platform for fashion and lifestyle products in Europe, with a market cap of approximately €6.91 billion.
Operations: The company’s revenue is primarily derived from its B2C segment, which accounts for €9.98 billion, and its B2B segment, contributing €1.01 billion.
Insider Ownership: 10.3%
Zalando shows promising growth with earnings expected to rise by 21.3% annually, outpacing the German market’s 16.7%. Although insider trading activity is not substantial recently, the stock trades at a significant discount to its estimated fair value. Recent financials reveal steady progress with H1 2025 sales of €5.25 billion and net income of €106.5 million, reflecting improved profitability despite slower revenue growth compared to high-growth benchmarks.
-
Delve into our full catalog of 195 Fast Growing European Companies With High Insider Ownership here.
-
Searching for a Fresh Perspective? Uncover the next big thing with financially sound penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include OM:YUBICO XTRA:RDC and XTRA:ZAL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Terms and Privacy Policy
Search
RECENT PRESS RELEASES
